<?xml version="1.0" encoding="UTF-8"?>
<ref id="B137-marinedrugs-17-00374" class="ref">
 <label class="label">137.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Arita</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yoshida</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hong</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tjonahen</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Glickman</surname>
    <given-names class="given-names">J.N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Petasis</surname>
    <given-names class="given-names">N.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Blumberg</surname>
    <given-names class="given-names">R.S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Serhan</surname>
    <given-names class="given-names">C.N.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis</article-title>
  <source class="source">Proc. Natl. Acad. Sci. USA</source>
  <year class="year">2005</year>
  <volume class="volume">102</volume>
  <fpage class="fpage">7671</fpage>
  <lpage class="lpage">7676</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1073/pnas.0409271102</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">15890784</pub-id>
 </element-citation>
</ref>
